伊利股份(600887.SH)及子公司健瓴資本擬共同出資設立健瓴母基金
格隆匯 8 月 3日丨伊利股份(600887.SH)公佈,為了實現對公司已投和未來擬投的私募股權基金和基金管理公司的統一專業化管理,提高投資風險管控能力,同時為了提升公司的產業拓展能力,尋求協同效應,有效把握新的市場機遇,公司及控股子公司珠海健瓴股權投資基金管理合夥企業(有限合夥)(“健瓴資本”)擬共同出資設立健瓴母基金,設立規模為20億元。
健瓴母基金主要投資於各類具有發展潛力的投資項目,包括具有良好投資能力的私募股權投資子基金、基金管理人及其他具有良好成長性的企業實體等,實現良好的投資效益,創造投資回報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.